Organization

German HIT-LOGGIC-Registry for LGG in children and adolescents, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

4 abstracts

Abstract
Clinical activity of pan-RAF inhibitor tovorafenib in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study.
Org: Children's National Hospital, Washington, DC, Duke University, Durham, NC, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom, CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX,
Abstract
LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
Org: Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Children's National Hospital, Washington, DC, Seattle Children’s Hospital, Orlando Health Arnold Palmer Hospital for Children,
Abstract
A basket-platform trial for neurofibromatosis type 1: A potential model for rare cancer predisposition syndromes.
Org: Novartis Pharmaceuticals, German HIT-LOGGIC-Registry for LGG in children and adolescents, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, SpringWorks Therapeutics, AstraZeneca,
Abstract
Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
Org: Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany, Swabian Children’s Cancer Center, Faculty of Medicine, University Augsburg, Augsburg, Germany, Division of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Division of Pediatric Neurosurgery, Department of Neurosurgery, Universitätsklinikum Heidelberg, Heidelberg, Germany, Department of Pediatric Neurosurgery, University Children's Hospital, University of Wuerzburg, Wuerzburg, Germany,